NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, will release its financial results for the quarter ended March 31, 2025, before market open on May 15. Management will host a conference call at 8:30 a.m. EDT the same day, led by Executive Chairman and CEO Charles M. Fernandez, CFO Cecile Munnik, and President and CEO…
Massimo (NASDAQ: MAMO) is making strategic moves to actively enhance its position in the powersports and recreational vehicle industry. The company is expanding its retail partnership with Rural King to include a wider range of products, while optimizing logistics with a new distribution center in Illinois and mitigating tariff risks and enhancing quality with Texas-based golf…
Freight Technologies, Inc. (Nasdaq: FRGT) has entered into a convertible note agreement for up to $20 million with an institutional investor, earmarking proceeds to purchase Official Trump Tokens ($TRUMP) as a core part of its crypto treasury. The initial $1 million tranche supports Fr8Tech’s broader digital asset diversification following its recent $8 million investment in…
HeartBeam (NASDAQ: BEAT) will host a conference call on May 13 at 4:30 p.m. Eastern to discuss financial results for the first quarter ended March 31, 2025. CEO Robert Eno and CFO Timothy Cruickshank will lead the call, which will include updates on regulatory progress, commercial-readiness efforts, and upcoming milestones. A corresponding press release and presentation…
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), advancing its Iska Iska silver-tin polymetallic project in southwestern Bolivia, will soon begin a 4,300-meter, eight-hole diamond drilling program targeting the Santa Barbara starter pit area. The campaign is designed to upgrade and expand high-grade tin and silver mineralization, with holes spaced at 50 meters to confirm…
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel photodynamic therapy designed to treat early-stage cutaneous T-cell lymphoma (“CTCL”). Building on the success of a prior phase 3 trial, HyBryte(TM)—which uses synthetic hypericin activated by safe visible light—offers a potentially game-changing approach by providing a…
HeartBeam (NASDAQ: BEAT) announced that its synthesized 12-lead ECG technology met clinical endpoints in the VALID-ECG pivotal study, achieving a 93.4% diagnostic agreement with standard 12-lead ECGs for arrhythmia assessment. Results were presented by Dr. Thomas Deering of Piedmont Heart Institute during the Heart Rhythm Society’s annual conference. HeartBeam’s 3D ECG technology, designed to fit into…
NextPlat (NASDAQ: NXPL, NXPLW) announced it has received a written notice from Nasdaq Stock Market LLC stating that the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as its closing bid price has remained below $1.00 per share for 30 consecutive business days. NextPlat has been granted a 180-calendar day period, until Oct. 27,…
Newton Golf Company (NASDAQ: NWTG) announced the launch of its newest shaft family, Newton Fast Motion, now available for purchase at a suggested retail price of $325. The lighter, Tour-proven shaft is engineered to deliver exceptional precision and enhanced swing speed, building on the company’s four core technologies: Elongated Bend Profile, Kinetic Energy Storage, Symmetry 360…
Nutriband Inc. (NTRB)
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software, and services, will release its first-quarter fiscal 2025 results before market open on Thursday, May 8, 2025. D-Wave will host a conference call featuring CEO Dr. Alan Baratz and CFO John Markovich at 8:00 a.m. ET that day to discuss…
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, is featured in a new Benzinga video detailing clinical progress for its lead candidate HyBryte™, which achieved a 75% response rate in a trial for cutaneous T-cell lymphoma (CTCL), a rare form of skin cancer. The trial is supported by funding from a U.S.…
Massimo Group (NASDAQ: MAMO), a manufacturer of powersports vehicles, is reinforcing its market position through strategic retail partnerships and a commitment to quality and innovation. By participating in key industry events like the Rural King Vendor Summit, the Tractor Supply Company and PetSense Annual Supplier Meeting and the Partner Trade Show, Massimo deepens ties with…
Thumzup (NASDAQ: TZUP) is shaking up the multibillion-dollar marketing industry with the launch of its patent-pending Lifestyle AI Agent Marketplace. The company’s new AI application, Gibberlink Advertising(TM)—GibberAds(TM)—empowers users with AI agents with expertise in areas like fashion and dining, enabling curated experiences, ranging from a first date to a personal spa getaway, based on preferences and…
HeartBeam (NASDAQ: BEAT), a medical technology firm innovating in personalized cardiac care, has announced a strategic collaboration with AccurKardia, a leader in ECG-based diagnostics. The partnership will integrate AccurKardia’s FDA-cleared ECG analysis software, AccurECG™, into HeartBeam’s compact, cable-free 3D ECG device. Designed to deliver 12-lead ECGs remotely, the device will be enhanced by automated arrhythmia…
Newton Golf Company (NASDAQ: NWTG), a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design, was featured in the GotStocks Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Dr. Greg Campbell, NWTG’s CEO, joined the program to discuss Newton Golf’s mission, vision and recent…
Calidi Biotherapeutics (NYSE American: CLDI) will host a live investor webinar on April 24, 2025, at 4:15 p.m. ET, featuring its new Chief Medical Officer, Dr. Guy Travis Clifton. The event will spotlight Calidi’s stem cell-based delivery platforms for oncolytic virus therapies, including the FDA-cleared CLD-201, which is advancing toward trials for solid tumors. Additional…
GivBux (OTC: GBUX) announced the finalized terms of its special dividend, with the Board approving a 1-for-10 warrant distribution for shareholders. For every 10 shares held, investors will receive one warrant to purchase GivBux common stock at $4.00 per share. The ex-dividend date is set for May 15, 2025, with distribution on May 21, 2025. The…